IL-1 antagonism with anakinra, as compared to no treatment in a subsequent observational study, may have the potential to mitigate androgen exposure in PCOS, with our results limited by the constraints of study design and sample size. This evidence concerns the gene IL1A and polycystic ovary syndrome.